Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Ashby

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Health Technology Assessment (Winchester, England)|November 22, 2021
Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCTSimon C Langton Hewer, Alan R Smyth, Michaela Brown, et al.
Pharmacoepidemiology and Drug Safety|November 3, 2015
Literature review of visual representation of the results of benefit-risk assessments of medicinal productsChristine E Hallgreen, Shahrul Mt-Isa, Alfons Lieftucht, et al.
JMIR Public Health and Surveillance|January 10, 2025
Strategies to Increase Response Rate and Reduce Nonresponse Bias in Population Health Research: Analysis of a Series of Randomized Controlled Experiments during a Large COVID-19 StudyChristina J Atchison, Nicholas Gilby, Galini Pantelidou, et al.
JAMA|August 3, 2016
Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical TrialAnthony C Gordon, Alexina J Mason, Neeraja Thirunavukkarasu, et al.
Nature Communications|February 17, 2022
Population antibody responses following COVID-19 vaccination in 212,102 individualsHelen Ward, Matthew Whitaker, Barnaby Flower, et al.
Intensive Care Medicine|August 21, 2019
Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trialDavid B Antcliffe, Shalini Santhakumaran, Robert M L Orme, et al.
The Lancet Regional Health. Europe|May 10, 2021
Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adultsHelen Ward, Graham S Cooke, Christina Atchison, et al.
Science (New York, N.Y.)|April 24, 2021
Resurgence of SARS-CoV-2: Detection by community viral surveillanceSteven Riley, Kylie E C Ainslie, Oliver Eales, et al.
Pharmacoepidemiology and Drug Safety|January 23, 2016
Recommendations for benefit-risk assessment methodologies and visual representationsDiana Hughes, Ed Waddingham, Shahrul Mt-Isa, et al.
British Journal of Clinical Pharmacology|August 13, 2011
Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420Tricia M Tan, Benjamin C T Field, James S Minnion, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Health Technology Assessment (Winchester, England)|November 22, 2021
Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCTSimon C Langton Hewer, Alan R Smyth, Michaela Brown, et al.
Pharmacoepidemiology and Drug Safety|November 3, 2015
Literature review of visual representation of the results of benefit-risk assessments of medicinal productsChristine E Hallgreen, Shahrul Mt-Isa, Alfons Lieftucht, et al.
JMIR Public Health and Surveillance|January 10, 2025
Strategies to Increase Response Rate and Reduce Nonresponse Bias in Population Health Research: Analysis of a Series of Randomized Controlled Experiments during a Large COVID-19 StudyChristina J Atchison, Nicholas Gilby, Galini Pantelidou, et al.
JAMA|August 3, 2016
Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical TrialAnthony C Gordon, Alexina J Mason, Neeraja Thirunavukkarasu, et al.
Nature Communications|February 17, 2022
Population antibody responses following COVID-19 vaccination in 212,102 individualsHelen Ward, Matthew Whitaker, Barnaby Flower, et al.
Intensive Care Medicine|August 21, 2019
Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trialDavid B Antcliffe, Shalini Santhakumaran, Robert M L Orme, et al.
The Lancet Regional Health. Europe|May 10, 2021
Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adultsHelen Ward, Graham S Cooke, Christina Atchison, et al.
Science (New York, N.Y.)|April 24, 2021
Resurgence of SARS-CoV-2: Detection by community viral surveillanceSteven Riley, Kylie E C Ainslie, Oliver Eales, et al.
Pharmacoepidemiology and Drug Safety|January 23, 2016
Recommendations for benefit-risk assessment methodologies and visual representationsDiana Hughes, Ed Waddingham, Shahrul Mt-Isa, et al.
British Journal of Clinical Pharmacology|August 13, 2011
Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420Tricia M Tan, Benjamin C T Field, James S Minnion, et al.
Pageof 13